M. Liontos, A. Andrikopoulou, K. Koutsoukos, C. Markellos, E. Skafida, O. Fiste, . . . F. Zagouri. (2021). Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy. BMC.
Chicago Style (17th ed.) CitationM. Liontos, et al. Neutrophil-to-lymphocyte Ratio and Chemotherapy Response Score as Prognostic Markers in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy. BMC, 2021.
MLA (9th ed.) CitationM. Liontos, et al. Neutrophil-to-lymphocyte Ratio and Chemotherapy Response Score as Prognostic Markers in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy. BMC, 2021.
Warning: These citations may not always be 100% accurate.